| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 98.427 | 62.619 | 83.034 | 109.809 | 188.758 |
| Total Income - EUR | - | - | - | - | 0 | 98.445 | 62.633 | 83.061 | 110.585 | 190.216 |
| Total Expenses - EUR | - | - | - | - | 832 | 79.142 | 55.584 | 69.070 | 88.038 | 151.717 |
| Gross Profit/Loss - EUR | - | - | - | - | -832 | 19.303 | 7.049 | 13.991 | 22.547 | 38.499 |
| Net Profit/Loss - EUR | - | - | - | - | -832 | 16.583 | 5.170 | 11.980 | 19.059 | 32.369 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Vivapro Medax S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 697 | 410 | 138 | 14.398 | 14.757 |
| Current Assets | - | - | - | - | 334 | 43.147 | 61.481 | 89.857 | 46.777 | 125.566 |
| Inventories | - | - | - | - | 0 | 219 | 40 | 427 | 3.946 | 329 |
| Receivables | - | - | - | - | 112 | 18.744 | 15.002 | 11.597 | 8.776 | 47.400 |
| Cash | - | - | - | - | 221 | 24.184 | 46.439 | 77.833 | 34.055 | 77.837 |
| Shareholders Funds | - | - | - | - | -790 | 15.809 | 5.210 | 17.496 | 36.502 | 32.409 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.149 | 28.035 | 56.680 | 72.499 | 25.242 | 108.545 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Vivapro Medax S.r.l.